SERHAN; Charles N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SERHAN; Charles N..The latest application filed is for "synthesis of pro-resolving analogs and compositions therefor".

Company Profile

8.79.107

SERHAN; Charles N. - West Roxbury MA
Serhan; Charles N. - Needham MA
Serhan; Charles N. - Neddham MA US
Serhan; Charles N. - Wellesley MA
Serhan; Charles N. - Boston MA
Serhan; Charles N. - Wellsley MA
Serhan; Charles N. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthesis Of Pro-resolving Analogs And Compositions Therefor App 20220288005 - VAN DYKE; Thomas E. ; et al.	2022-09-15
Lipoxin A4 Analogs And Uses Thereof App 20210401798 - CHIANG; Nan ; et al.	2021-12-30
Cysteinyl-proresolving Mediators That Promote Resolution Of Infection And Organ Protection App 20210322441 - Serhan; Charles N. ; et al.	2021-10-21
Cysteinyl-proresolving mediators that promote resolution of infection and organ protection Grant 11,135,228 - Serhan , et al. October 5, 2	2021-10-05
Compounds and Methods for Modulating Vascular Injury App 20200113861 - Conte; Michael S. ; et al.	2020-04-16
Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections App 20200048177 - Dalli; Jesmond ; et al.	2020-02-13
Novel N-3 Immunoresolvents: Structures and Actions App 20200010398 - SERHAN; Charles N. ; et al.	2020-01-09
Alx Receptor Ligands Define A Biochemical Endotype For Inflammation-based Diseases App 20190391145 - Levy; Bruce ; et al.	2019-12-26
Personalized Metabolomic Profiling of Specialized Pro-Resolving Mediators App 20190346462 - Serhan; Charles N. ; et al.	2019-11-14
14-hydroxy-docosahexaenoic acid compounds Grant 10,239,850 - Serhan , et al.	2019-03-26
14-hydroxy-docosahexaenoic acid compounds Grant 10,233,167 - Serhan , et al.	2019-03-19
14-hydroxy-docosahexaenoic acid compounds Grant 10,233,168 - Serhan , et al.	2019-03-19
Docosahexaenoyl ethanolamides Grant 10,227,291 - Serhan , et al.	2019-03-12
Anti-inflammatory particles Grant 10,154,977 - Serhan , et al. Dec	2018-12-18
Compounds and methods for modulating vascular injury Grant 10,111,847 - Conte , et al. October 30, 2	2018-10-30
Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections App 20180208536 - Dalli; Jesmond ; et al.	2018-07-26
Novel N-3 Immunoresolvents: Structures and Actions App 20180118654 - SERHAN; Charles N. ; et al.	2018-05-03
N-3 immunoresolvents: structures and actions Grant 9,902,681 - Serhan , et al. February 27, 2	2018-02-27
14-hydroxy-docosahexaenoic Acid Compounds App 20170349560 - SERHAN; Charles N. ; et al.	2017-12-07
14-hydroxy-docosahexaenoic Acid Compounds App 20170320841 - SERHAN; Charles N. ; et al.	2017-11-09
14-hydroxy-docosahexaenoic Acid Compounds App 20170283388 - SERHAN; Charles N. ; et al.	2017-10-05
Oxylipin-peptide Conjugated Mediators That Promote Resolution Of Infection, Organ Protection And Tissue Regeneration App 20170258806 - SERHAN; Charles N. ; et al.	2017-09-14
Compounds and Methods for Modulating Vascular Injury App 20170216238 - Conte; Michael S. ; et al.	2017-08-03
14-hydroxy-docosahexaenoic acid compounds Grant 9,611,240 - Serhan , et al. April 4, 2	2017-04-04
14-hydroxy-docosahexaenoic acid compounds Grant 9,611,239 - Serhan , et al. April 4, 2	2017-04-04
14-hydroxy-docosahexaenoic acid compounds Grant 9,611,238 - Serhan , et al. April 4, 2	2017-04-04
Docosahexaenoyl Ethanolamides App 20160311761 - Serhan; Charles N. ; et al.	2016-10-27
Compounds and methods for modulating vascular injury Grant 9,463,177 - Conte , et al. October 11, 2	2016-10-11
Docosahexaenoyl ethanolamides Grant 9,416,118 - Serhan , et al. August 16, 2	2016-08-16
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers Grant 9,364,454 - Serhan , et al. June 14, 2	2016-06-14
Novel N-3 Immunoresolvents: Structures And Actions App 20160115112 - SERHAN; Charles N. ; et al.	2016-04-28
Compounds and Methods for Modulating Vascular Injury App 20150216829 - Conte; Michael S. ; et al.	2015-08-06
14-hydroxy-docosahexaenoic Acid Compounds App 20150119460 - SERHAN; Charles N. ; et al.	2015-04-30
14-hydroxy-docosahexaenoic Acid Compounds App 20150119463 - SERHAN; Charles N. ; et al.	2015-04-30
14-hydroxy-docosahexaenoic Acid Compounds App 20150119462 - SERHAN; Charles N. ; et al.	2015-04-30
Docosahexaenoyl Ethanolamides App 20150025257 - Serhan; Charles N. ; et al.	2015-01-22
Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma Grant 8,933,270 - Serhan , et al. January 13, 2	2015-01-13
14-hydroxy-docosahexaenoic acid compounds Grant 8,927,747 - Serhan , et al. January 6, 2	2015-01-06
Use Of Docasatrienes, Resolvins, And Their Stable Analogs In The Treatment Of Airway Diseases And Asthma App 20140179630 - SERHAN; Charles N. ; et al.	2014-06-26
Lipoxin analogs as novel inhibitors of angiogenesis Grant 8,722,654 - Serhan , et al. May 13, 2	2014-05-13
Lipoxin Analogs As Novel Inhibitors Of Angiogenesis App 20140094519 - Serhan; Charles N. ; et al.	2014-04-03
Anti-inflammatory Particles App 20140079631 - Serhan; Charles N. ; et al.	2014-03-20
Lipoxin analogs and methods for the treatment of periodontal disease Grant 8,604,229 - Van Dyke , et al. December 10, 2	2013-12-10
Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma Grant 8,569,542 - Serhan , et al. October 29, 2	2013-10-29
Resolvins: Bioemplates For Novel Therapeutic Interventions App 20130217771 - Serhan; Charles N.	2013-08-22
Anti-inflammatory Actions Of Neuroprotectin D1/protectin D1 And Its Natural Stereoisomers App 20130150446 - Serhan; Charles N. ; et al.	2013-06-13
Modulation of inflammation related to columnar epithelia Grant 8,440,718 - Madara , et al. May 14, 2	2013-05-14
Aspirin-triggered lipid mediators Grant 8,349,896 - Serhan , et al. January 8, 2	2013-01-08
Lipoxin Compounds And Their Use In Treating Cell Proliferative Disorders App 20120277311 - Serhan; Charles N.	2012-11-01
Use Of Docosatrienes, Resolvins, And Their Stable Analogs In The Treatment Of Airway Diseases And Asthma App 20120264713 - Serhan; Charles N. ; et al.	2012-10-18
Method For Treating Neuropathic Pain App 20120245229 - Ji; Ru-Rong ; et al.	2012-09-27
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers Grant 8,273,792 - Serhan , et al. September 25, 2	2012-09-25
Method For Treating Airway Hyper-responsiveness With Lipoxin Analogs App 20120149771 - Serhan; Charles N. ; et al.	2012-06-14
Lipoxin Analogs And Methods For The Treatment Of Periodontal Disease App 20120114566 - Van Dyke; Thomas E. ; et al.	2012-05-10
Method for treating airway hyper-responsiveness with lipoxin analogs Grant 8,119,691 - Serhan , et al. February 21, 2	2012-02-21
Prevention Of Neutrophil Recruitment App 20120010286 - Serhan; Charles N.	2012-01-12
Lipoxin analogs and methods for the treatment of periodontal disease Grant 8,093,417 - Van Dyke , et al. January 10, 2	2012-01-10
Use Of Novel Lipid Mediators To Inhibit Angiogenesis App 20110301239 - Serhan; Charles N. ; et al.	2011-12-08
14-hydroxy-docosahexaenoic Acid Compounds App 20110288317 - Serhan; Charles N. ; et al.	2011-11-24
Functional Metabolomics Coupled Microfluidic Chemotaxis Device And Identification Of Novel Cell Mediators App 20110237495 - Serhan; Charles N. ; et al.	2011-09-29
Prevention of neutrophil recruitment Grant 8,022,105 - Serhan September 20, 2	2011-09-20
Lipoxin analogs as novel inhibitors of angiogenesis Grant 8,008,282 - Serhan , et al. August 30, 2	2011-08-30
Approach to anti-microbial host defense with molecular shields with lipoxin compounds Grant 7,994,219 - Serhan , et al. August 9, 2	2011-08-09
Lipoxin Analogs And Methods For The Treatment Of Periodontal Disease App 20110064677 - Van Dyke; Thomas E. ; et al.	2011-03-17
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma Grant 7,872,152 - Serhan , et al. January 18, 2	2011-01-18
Lipoxin compounds and their use in treating cell proliferative disorders Grant 7,825,271 - Serhan November 2, 2	2010-11-02
Lipoxin analogs and methods for the treatment of periodontal disease Grant 7,812,054 - Van Dyke , et al. October 12, 2	2010-10-12
Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors Grant 7,803,557 - Serhan , et al. September 28, 2	2010-09-28
Aspirin-triggered Lipid Mediators App 20100216882 - Serhan; Charles N. ; et al.	2010-08-26
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma Grant 7,759,395 - Serhan , et al. July 20, 2	2010-07-20
Lipoxin compounds and their use in treating cell proliferative disorders Grant 7,741,369 - Serhan June 22, 2	2010-06-22
Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs Grant 7,741,368 - Serhan , et al. June 22, 2	2010-06-22
Aspirin-triggered lipid mediators Grant 7,737,178 - Serhan , et al. June 15, 2	2010-06-15
Aspirin-triggered lipid mediators Grant 7,709,669 - Serhan , et al. May 4, 2	2010-05-04
Use Of Resolvins And Docosatrienes And Analogues Thereof For The Treatment Of Angiogenesis And Ocular Neovascularization App 20100105773 - Smith; Lois ; et al.	2010-04-29
Use Of Novel Lipid Mediators To Inhibit Angiogenesis App 20100105772 - Serhan; Charles N. ; et al.	2010-04-29
Lipoxin analogs and method for the treatment of periodontal disease Grant 7,700,650 - Van Dyke , et al. April 20, 2	2010-04-20
Prevention Of Neutrophil Recruitment App 20100048702 - Serhan; Charles N.	2010-02-25
Resolvins: Biotemplates For Novel Therapeutic Interventions App 20100016432 - SERHAN; CHARLES N.	2010-01-21
Lipoxin Analogs And Methods For The Treatment Of Periodontal Disease App 20090311201 - Van Dyke; Thomas E. ; et al.	2009-12-17
Prevention of neutrophil recruitment Grant 7,615,576 - Serhan November 10, 2	2009-11-10
Lipoxin Compounds and Their use in Treating Cell Proliferative Disorders App 20090270498 - Serhan; Charles N.	2009-10-29
Lipoxin Compounds and Their Use in Treating Cell Proliferative Disorders App 20090258945 - Serhan; Charles N.	2009-10-15
Analogues of lipid mediators derived from .omega.-3 PUFAs and methods of use Grant 7,595,341 - Goodman , et al. September 29, 2	2009-09-29
Resolvins: Biotemplates for novel therapeutic interventions Grant 7,585,856 - Serhan September 8, 2	2009-09-08
Prevention of neutrophil recruitment Grant 7,579,494 - Serhan August 25, 2	2009-08-25
Methods For Identification And Uses Of Anti-inflammatory Receptors For Eicosapentaenoic Acid Analogs App 20090180961 - Serhan; Charles N. ; et al.	2009-07-16
Anti-inflammatory Actions Of Neuroprotectin D1/protectin D1 And It's Natural Stereoisomers App 20090156673 - Serhan; Charles N. ; et al.	2009-06-18
Aspirin-Triggered Lipid Mediators App 20090149538 - Serhan; Charles N. ; et al.	2009-06-11
Inhibition of TNF-alpha-Initiated Response App 20080312323 - Serhan; Charles N.	2008-12-18
Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds App 20080214665 - Serhan; Charles N. ; et al.	2008-09-04
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use App 20080207753 - Goodman; Daniel W. ; et al.	2008-08-28
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use Grant 7,378,444 - Goodman , et al. May 27, 2	2008-05-27
Use of Docosatrienes, Resolvins and Their Stable Analogs in the Treatment of Airway Diseases and Asthma App 20080096961 - Serhan; Charles N. ; et al.	2008-04-24
Inhibition of TNF-alpha-Initiated Neutrophil Response App 20080081838 - Serhan; Charles N.	2008-04-03
Prevention of Neutrophil Recruitment App 20080064747 - Serhan; Charles N.	2008-03-13
Modulation of Inflammation Related to Columnar Epithelia App 20080064660 - Madara; James L. ; et al.	2008-03-13
Lipoxin Analogs as Novel Inhibitors of Angiogenesis App 20080064749 - Serhan; Charles N. ; et al.	2008-03-13
Regulation of Phospholipase D Activity App 20080064751 - Serhan; Charles N.	2008-03-13
Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases App 20080064746 - Serhan; Charles N. ; et al.	2008-03-13
Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs Grant 7,341,840 - Serhan , et al. March 11, 2	2008-03-11
Lipoxin compounds and their use in treating cell proliferative disorders Grant 7,294,728 - Serhan November 13, 2	2007-11-13
Prevention of Neutrophil Recruitment App 20070259958 - Serhan; Charles N.	2007-11-08
Lipoxin compounds and their use in treating cell proliferative disorders Grant 7,288,569 - Serhan October 30, 2	2007-10-30
Prevention of neutrophil recruitment Grant 7,227,031 - Serhan June 5, 2	2007-06-05
Aspirin-triggered lipid mediators App 20070049639 - Serhan; Charles N. ; et al.	2007-03-01
Use of resolvins to treat gastrointestinal diseases App 20060293288 - Serhan; Charles N. ; et al.	2006-12-28
Inhibition of TNF-.alpha.-initiated neutrophil response Grant 7,132,451 - Serhan November 7, 2	2006-11-07
Novel approach to antimicrobial host defense with molecular shields with EPA and DHA analogs App 20060128804 - Serhan; Charles N. ; et al.	2006-06-15
Aspirin-triggered lipid mediators Grant 7,053,230 - Serhan , et al. May 30, 2	2006-05-30
Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs Grant 7,030,159 - Serhan , et al. April 18, 2	2006-04-18
Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases App 20060079577 - Serhan; Charles N. ; et al.	2006-04-13
Lipoxin compounds and their use in treating cell proliferative disorders App 20060069158 - Serhan; Charles N.	2006-03-30
Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs App 20060024758 - Serhan; Charles N. ; et al.	2006-02-02
Lipoxin analogs as novel inhibitors of angiogenesis App 20060009521 - Serhan; Charles N. ; et al.	2006-01-12
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma App 20050261255 - Serhan, Charles N. ; et al.	2005-11-24
Prevention of neutrophil recruitment Grant 6,960,674 - Serhan November 1, 2	2005-11-01
Methods and compositions for preventing or treating periodontal diseases App 20050238589 - Van Dyke, Thomas E. ; et al.	2005-10-27
Prevention of neutrophil recruitment App 20050192350 - Serhan, Charles N.	2005-09-01
Regulation of phospholipase D activity App 20050187294 - Serhan, Charles N.	2005-08-25
Regulation of phospholipase D activity Grant 6,927,238 - Serhan August 9, 2	2005-08-09
Lipoxin compounds and their use in treating cell proliferative disorders App 20050148668 - Serhan, Charles N.	2005-07-07
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,887,901 - Serhan May 3, 2	2005-05-03
Neuroprotectin D1 protects against cellular apoptosis, stroke damage, alzheimer's disease and retinal diseases App 20050075398 - Bazan, Nicolas G. ; et al.	2005-04-07
Regulation of phospholipase D activity Grant 6,864,288 - Serhan March 8, 2	2005-03-08
Inhibition of TNF-alpha-initiated neutrophil response App 20040192785 - Serhan, Charles N.	2004-09-30
Modulation of inflammation related to columnar epithelia App 20040151712 - Madara, James L. ; et al.	2004-08-05
Resolvins: biotemplates for novel therapeutic interventions App 20040116408 - Serhan, Charles N.	2004-06-17
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,750,360 - Serhan June 15, 2	2004-06-15
Prevention of neutrophil recruitment Grant 6,720,354 - Serhan April 13, 2	2004-04-13
Aspirin-triggered lipid mediators App 20040059144 - Serhan, Charles N. ; et al.	2004-03-25
Inhibition of TNF.alpha.-initiated neutrophil response Grant 6,710,084 - Serhan March 23, 2	2004-03-23
Lipoxin analogs as novel inhibitors of angiogenesis App 20040053998 - Serhan, Charles N. ; et al.	2004-03-18
Inhibition of TNF.alpha.-initiated neutrophil response Grant 6,703,423 - Serhan March 9, 2	2004-03-09
Modulation of inflammation related to columnar epithelia Grant 6,699,905 - Madara , et al. March 2, 2	2004-03-02
Lipoxin analogs and method for the treatment of periodontal disease App 20040019110 - Van Dyke, Thomas E. ; et al.	2004-01-29
Aspirin-triggered lipid mediators Grant 6,670,396 - Serhan , et al. December 30, 2	2003-12-30
Prevention of neutrophil recruitment Grant 6,659,282 - Serhan December 9, 2	2003-12-09
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,653,493 - Serhan November 25, 2	2003-11-25
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,635,776 - Serhan October 21, 2	2003-10-21
Novel approach to anti-microbial host defense with molecular shields with lipoxin compounds App 20030195248 - Serhan, Charles N. ; et al.	2003-10-16
Novel approach to anti-microbial host defense with molecular shields with EPA and DHA analogs App 20030191184 - Serhan, Charles N. ; et al.	2003-10-09
Prevention of neutrophil recruitment App 20030191332 - Serhan, Charles N.	2003-10-09
Lipoxin analogs as novel inhibitors of angiogenesis Grant 6,627,658 - Serhan , et al. September 30, 2	2003-09-30
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,620,919 - Serhan September 16, 2	2003-09-16
Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases App 20030166716 - Serhan, Charles N. ; et al.	2003-09-04
Lipoxin compounds and their use in treating cell proliferative disorders App 20030134901 - Serhan, Charles N.	2003-07-17
Prevention Of Neutrophil Recruitment App 20030069435 - Serhan, Charles N.	2003-04-10
Modulation of inflammation related to columnar epithelia App 20030060512 - Madara, James L. ; et al.	2003-03-27
Prevention of neutrophil recruitment App 20030055275 - Serhan, Charles N.	2003-03-20
Lipoxin compounds and their use in treating cell proliferative disorders App 20030032827 - Serhan, Charles N.	2003-02-13
Lipoxin analogs as novel inhibitors of angiogenesis App 20020193431 - Serhan, Charles N. ; et al.	2002-12-19
Inhibition of TNF-alpha-initiated neutrophil response App 20020143069 - Serhan, Charles N.	2002-10-03
Inhibition of TNF-alpha-initiated neutrophil response App 20020132847 - Serhan, Charles N.	2002-09-19
Regulation of phospholipase D activity App 20020120013 - Serhan, Charles N.	2002-08-29
Lipoxin compounds and their use in treating cell proliferative disorders App 20020111505 - Serhan, Charles N.	2002-08-15
Regulation of phospholipase D activity App 20020107289 - Serhan, Charles N.	2002-08-08
Screening methods for presqualene diphosphate analogs App 20020094549 - Serhan, Charles N. ; et al.	2002-07-18
Lipoxin compounds and their use in treating cell proliferative disorders App 20020091279 - Serhan, Charles N.	2002-07-11
Lipoxin compounds and their use in treating cell proliferative disorders App 20020082435 - Serhan, Charles N.	2002-06-27
Aspirin-triggered lipid mediators App 20020055538 - Serhan, Charles N. ; et al.	2002-05-09
Modulation of inflammation related to columnar epithelia App 20020045579 - Madara, James L. ; et al.	2002-04-18
Lipoxin compounds and their use in treating cell proliferative disorders App 20020010351 - Serhan, Charles N.	2002-01-24
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,316,648 - Serhan November 13, 2	2001-11-13
Lipoxin compounds and their use in treating cell proliferative disorders App 20010031882 - Serhan, Charles N.	2001-10-18
Leukotriene B4 receptor transgenic mice App 20010023500 - Serhan, Charles N.	2001-09-20
Screening methods for presqualene diphosphate analogs Grant 6,251,622 - Serhan , et al. June 26, 2	2001-06-26
Screening methods for presqualene diphosphate analogs App 20010001062 - Serhan, Charles N. ; et al.	2001-05-10
Lipoxin compounds and their use in treating cell proliferative disorders Grant 6,048,897 - Serhan April 11, 2	2000-04-11
Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses Grant 6,008,205 - Serhan , et al. December 28, 1	1999-12-28
Modulation of inflammation related to columnar epithelia Grant 5,650,435 - Madara , et al. July 22, 1	1997-07-22
Lipoxin compounds Grant 5,441,951 - Serhan August 15, 1	1995-08-15
Use of lipoxin A.sub.4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis Grant 5,079,261 - Serhan , et al. January 7, 1	1992-01-07

Company Registrations

NCAGE Code	4CU06	SERHAN, CHARLES N
CAGE Code	4CU06	SERHAN, CHARLES N

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.